ROBAFEN CF COUGH AND COLD- guaifenesin, dextromethorphan hydrobromide, and phenylephrine hydrochloride solution 
Major Pharmaceuticals

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

----------

Robafen® CF Cough & cold

Drug Facts

Active ingredients (in each TSP (5 mL))Purpose

Dextromethorphan HBr USP 10mg

Cough suppressant

Guaifenesin USP 100mg

Expectorant

Phenylephrine HCL USP 5 mg

Nasal Decongestant

Uses

Helps loosen phlegm (mucus) and thin bronchial secretions to drain bronchial tubes
Temporarily relieves these symptoms occurring with a cold:
nasal congestion.
cough due to minor throat and bronchial irritation.

Warnings

Do not use if you are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric or emotional conditions, or Parkinsons disease), or for 2 weeks after stopping the MAOI drug. If you do not know if your prescription drug contains an MAOI, ask a doctor or pharmacist before taking this product.

Ask a doctor before use if you have

Heart disease
Diabetes
High blood pressure
Thyroid disease
Cough that lasts or is chronic such as occurs with smoking, asthma, chronic bronchitis, or emphysema
Cough that occurs with too much phlegm (mucus)
Trouble urinating due to an enlarged prostate gland

When using this product

do not use more than directed

Stop use and ask a doctor if

you get nervous, dizzy, or sleepless.
symptoms do not get better within 7 days or are accompanied by fever.
cough lasts more than 7 days, comes back, or is accompanied by fever, rash, or persistent headache. These could be signs of a serious condition.

If pregnant or breast feeding, ask a health professional before use.

Keep out of reach of children. In case of accidental overdose, seek professional assistance or contact a Poison Control Center immediately.

Directions

Do not exceed 6 doses in any 24 hour period

age

dose

Adults and children 12 years and over

2 TSP (teaspoonful) every 4 hours

children under 12 years

do not use

Other Information

Dosage cup provided.
Each TSP (5ml) contains: sodium 4mg.
Store at 20 - 25 ˚C(68-77 ˚F).

Inactive Ingredients

citric acid, flavor, glycerin, menthol, propylene glycol, purified water, FD&C Red # 40, sodium benzoate, sodium saccharin, sorbitol.

Questions or Comments?

1-800-616-2471

 
Distributed by: MAJOR® PHARMACEUTICALS
31778 Enterprise Drive
Livonia, MI 48150 USA

PRINCIPAL DISPLAY PANEL - 118 mL Bottle Carton

See New
Dosing Information

NDC 0904-6309-20

MAJOR®

ROBAFEN®

CF
COUGH
& COLD

COUGH SUPPRESSANT (Dextromethorphan HBr)
EXPECTORANT (Guaifenesin)
NASAL DECONGESTANT (Phenylephrine HCL)

Relieves:

Cough
Stuffy Nose
Chest Congestion

Non-Drowsy

COMPARE TO the active
ingredients of ROBITUSSIN® CF*

FOR AGES 12 AND OVER

4 FL OZ (118 mL)

PRINCIPAL DISPLAY PANEL - 118 mL Bottle Carton
ROBAFEN CF COUGH AND COLD 
guaifenesin, dextromethorphan hydrobromide, and phenylephrine hydrochloride solution
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:0904-6309
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
Guaifenesin (UNII: 495W7451VQ) (Guaifenesin - UNII:495W7451VQ) Guaifenesin100 mg  in 5 mL
Dextromethorphan Hydrobromide (UNII: 9D2RTI9KYH) (Dextromethorphan - UNII:7355X3ROTS) Dextromethorphan Hydrobromide10 mg  in 5 mL
Phenylephrine Hydrochloride (UNII: 04JA59TNSJ) (Phenylephrine - UNII:1WS297W6MV) Phenylephrine Hydrochloride5 mg  in 5 mL
Inactive Ingredients
Ingredient NameStrength
Water (UNII: 059QF0KO0R)  
Sodium Benzoate (UNII: OJ245FE5EU)  
Saccharin Sodium (UNII: SB8ZUX40TY)  
Anhydrous Citric Acid (UNII: XF417D3PSL)  
Glycerin (UNII: PDC6A3C0OX)  
Propylene Glycol (UNII: 6DC9Q167V3)  
MENTHOL, UNSPECIFIED FORM (UNII: L7T10EIP3A)  
Cherry (UNII: BUC5I9595W)  
Sorbitol (UNII: 506T60A25R)  
FD&C Red NO. 40 (UNII: WZB9127XOA)  
Product Characteristics
ColorREDScore    
ShapeSize
FlavorCHERRYImprint Code
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:0904-6309-201 in 1 CARTON03/05/201304/29/2019
1118 mL in 1 BOTTLE; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph finalpart34103/05/201304/29/2019
Labeler - Major Pharmaceuticals (191427277)

Revised: 8/2018
 
Major Pharmaceuticals